Serum proteomic profiling of physical activity reveals CD300LG as a novel exerkine with a potential causal link to glucose homeostasis.
Lee-Ødegård S, Hjorth M, Olsen T, Moen GH, Daubney E, Evans DM, Hevener AL, Lusis AJ, Zhou M, Seldin MM, Allayee H, Hilser J, Viken JK, Gulseth H, Norheim F, Drevon CA, Birkeland KI.
Lee-Ødegård S, et al. Among authors: viken jk.
Elife. 2024 Aug 27;13:RP96535. doi: 10.7554/eLife.96535.
Elife. 2024.
PMID: 39190027
Free PMC article.
Clinical Trial.